BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21896409)

  • 1. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative acetylcholinesterase (AChE)--determination in amniotic fluid--potential for differential diagnosis in consistently high AFP levels during general AFP screening for prenatal diagnosis of open neural tube defects].
    Zwahr C; Grosch A; Horn A; Schulze M
    Zentralbl Gynakol; 1989; 111(19):1285-92. PubMed ID: 2480036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis of neural tube and abdominal wall defects in the 2d trimester].
    Mühlhaus K; Weitzel HK; Schneider J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):98-100. PubMed ID: 2579872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
    Lopez J; Mikaelian I; Gonzalo P
    Prenat Diagn; 2013 Oct; 33(10):990-5. PubMed ID: 23784867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amniotic fluid alpha-fetoprotein and acetylcholinesterase in early genetic amniocentesis.
    Drugan A; Syner FN; Greb A; Evans MI
    Obstet Gynecol; 1988 Jul; 72(1):35-8. PubMed ID: 2454439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical markers of neural tube closure defects during the second half of pregnancy].
    Guibaud S; Boisson C; Simplot A; Thoulon JM
    J Genet Hum; 1988 Aug; 36(4):337-46. PubMed ID: 2464664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population.
    Fisher NL; Luthy DA; Peterson A; Karp LE; Williamson R; Cheng E
    Am J Med Genet; 1981; 9(3):201-9. PubMed ID: 6169278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
    Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
    Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.
    Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amniotic and serum alphafetoprotein in the chick embryo with neural tube defect].
    Uriarte S; Barrena MJ; López de Torre B; Aldazábal P; Cuadrado E; Tovar JA
    Cir Pediatr; 1993 Jul; 6(3):137-40. PubMed ID: 7692911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
    Allen LC; Doran TA; Miskin M; Rudd NL; Benzie RJ; Sheffield LJ
    Obstet Gynecol; 1982 Aug; 60(2):169-73. PubMed ID: 6185890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation.
    Flick A; Krakow D; Martirosian A; Silverman N; Platt LD
    Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein and acetylcholinesterase activity in first- and early second-trimester amniotic fluid.
    Jørgensen FS; Sundberg K; Loft AG; Arends J; Nørgaard-Pedersen B
    Prenat Diagn; 1995 Jul; 15(7):621-5. PubMed ID: 8532621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of neural tube defects.
    Dembert ML; Harisiades JP
    Am Fam Physician; 1983 Feb; 27(2):241-4. PubMed ID: 6187201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.